Late hypertension after liver transplantation: A comparison of cyclosporine and tacrolimus (FK 506)

Liver Transplantation and Surgery

Volumn 4, Issue 4, 1998, Pages 328-334

  Canzanello, V J ^a   Textor, S C ^a   Taler, S J ^a   Schwartz, L L ^a   Porayko, M K ^a   Wiesner, R H ^a   Krom, R A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; TACROLIMUS;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; BODY WEIGHT; CLINICAL TRIAL; DRUG EFFECT; FAMILY HISTORY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREVALENCE; PRIORITY JOURNAL;

EID: 0031878229     PISSN: 10743022     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.500040404     Document Type: Article

References (31)

1. 1 Textor SC. De novo hypertension after liver transplantation. Hypertension 1993 ; 22: 257–267. MEDLINE
2. 2 Textor SC, Canzanello VJ, Taler SJ, Wilson DJ, Schwartz LL, Augustine JE, et al. Cyclosporine‐induced hypertension after transplantation. Mayo Clin Proc 1994 ; 69: 1182–1193. MEDLINE
3. 3 Textor SC, Burnett JC, Romero JC, Canzanello VJ, Taler SJ, Wiesner R, et al. Urinary endothelin and renal vasoconstriction with cyclosporine or FK506 after liver transplantation. Kidney Int 1995 ; 47: 1426–1433. MEDLINE
4. 4 Ellis D, Shapiro R, Jordan ML, Scantlebury VP, Gilboa N, Hopp L. Comparison of FK‐506 and cyclosporine regimens in pediatric renal transplantation. Pediatr Nephrol 1994 ; 8: 193–200. MEDLINE
5. 5 Kokado Y, Takahara S, Kameoka H, Okuyama A. Hypertension in renal transplant recipients and its effect on long‐term renal allograft survival. Transplant Proc 1996 ; 28: 1600–1602. MEDLINE
6. 6 Pirsch JD, Miller J, Deierhol MH, Vincenti F, Filo FS. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Transplantation 1997 ; 63: 977–983. MEDLINE
7. 7 Swenson JM, Fricker FJ, Armitage JM. Immunosuppression switch in pediatric heart transplant recipients: Cyclosporine to FK506. J Am Coll Cardiol 1995 ; 25: 1183–1188. MEDLINE
8. 8 Pham SM, Kormos RL, Kawai A, Murali S, Hattler BG, Demetris AJ, et al. Tacrolimus (FK506) in clinical cardiac transplantation: A five year experience. Transplant Proc 1996 ; 28: 1002–1004. MEDLINE
9. 9 Pham SM, Kormos RL, Hattler BG, Kawai A, Tsamandas AC, Demetris AJ. A prospective trial of tacrolimus (FK 506) in clinical heart transplantation: Intermediate‐term results. J Thorac Cardiovasc Surg 1996 ; 111: 764–772. MEDLINE
10. 10 Todo S, Fung JJ, Demetris AJ, Jain A, Alessiani M, Takaya S, et al. One hundred ten consecutive primary orthotopic liver transplants under FK506 in adults. Transplant Proc 1991 ; 23: 1397–1402. MEDLINE
11. 11 Canzanello VJ, Schwartz L, Taler SJ, Textor SC, Wiesner RH, Porayko MK, et al. Evolution of cardiovascular risk after liver transplantation: A comparison of cyclosporine A and tacrolimus (FK506). Liver Transplant Surg 1997 ; 3: 1–9.
12. 12 Clark W. Tacrolimus: Immunosuppression following liver and kidney transplant. J Clin Pharm Ther 1996 ; 21: 135–141. MEDLINE
13. 13 The U.S. Multicenter FK 506 Liver Study Group. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994 ; 331: 1110–1115. MEDLINE
14. 14 Schwartz L, Raymer J, Canzanello V, Taler S, Textor S. Nurse management of posttransplant hypertension in liver transplant recipients. J Transpl Coord 1996 ; 6: 139–144. MEDLINE
15. 15 Porayko MK, Textor SC, Krom RAF, Hay JE, Gores GJ, Richards TM, et al. Nephrotoxic effects of primary immunosuppression with FK‐506 and cyclosporine regimens after liver transplantation. Mayo Clin Proc 1994 ; 69: 105–111. MEDLINE
16. 16 Jusko WJ, D'Ambrosio R. Monitoring FK506 concentrations in plasma and whole blood. Transplant Proc 1991 ; 23: 2732–2735. MEDLINE
17. 17 Canzanello VJ, Textor SC, Taler SJ, Wilson DJ, Schwartz L, Wiesner RH, et al. Renal sodium handling with cyclosporin A and FK506 after orthotopic liver transplantation. J Am Soc Nephrol 1995 ; 5: 1910–1917. MEDLINE
18. 18 Monsour HP, Wood RP, Dyer CH, Galati JS, Ozaki CF, Clark JH. Renal insufficiency and hypertension as long‐term complications in liver transplantation. Semin Liver Dis 1995 ; 15: 123–132. MEDLINE
19. 19 Textor SC, Wilson DJ, Lerman A, Romero JC, Burnett JC, Wiesner R, et al. Renal hemodynamics, urinary eicosanoids, and endothelin after liver transplantation. Transplantation 1992 ; 54: 74–80. MEDLINE
20. 20 Textor SC, Wiesner R, Wilson DJ, Porayko M, Romero JC, Burnett JC, et al. Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients. Transplantation 1993 ; 55: 1332–1339. MEDLINE
21. 21 Taler SJ, Textor SC, Canzanello VJ, Schwartz L, Porayko M, Wiesner RH, et al. Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine. Transplantation 1996 ; 62: 1588–1592. MEDLINE
22. 22 Textor SC, Schwartz L, Canzanello VJ, Wiesner RH, Taler SJ, Porayko M, et al. Resolution of posttransplant hypertension after liver transplantation despite impaired glomerular filtration. J Am Soc Nephrol 1994 ; 5: 1223–1230. MEDLINE
23. 23 Schmieder RE, Messerli FH. Obesity hypertension. Med Clin North Am 1987 ; 71: 991–1001. MEDLINE
24. 24 Brazy PC, Stead WW, Fitzwilliam JF. Progression of renal insufficiency: Role of blood pressure. Kidney Int 1989 ; 35: 670–674. MEDLINE
25. 25 Paul LC, Benediktsson H. Post‐transplant hypertension and chronic renal allograft failure. Kidney Int 1995 ; 48 (suppl 52): S34–S37.
26. 26 Sanders CE Jr, Curtis JJ. Role of hypertension in chronic renal allograft dysfunction. Kidney Int 1995 ; 48 (suppl 52): S43–S47.
27. 27 Sehgal V, Radhakrishnan J, Appel GB, Valeri A, Cohen DJ. Progressive renal insufficiency following cardiac transplantation: Cyclosporine, lipids, and hypertension. Am J Kidney Dis 1995 ; 26: 193–201. MEDLINE
28. 28 Klintmalm GB, Gonwa TA. Nephrotoxicity associated with cyclosporine and FK506. Liver Transplant Surg 1995 ; 1: 11–19.
29. 29 Seifeldin R, Marcos‐Alvarez A, Lewis WD, Gordan FD, Jenkins RL. Effect of nifedipine on renal function in liver transplant recipients receiving tacrolimus. Clin Ther 1996 ; 18: 491–496. MEDLINE
30. 30 Frei U, Wagner K. Renal function in liver transplant patients receiving FK506 or cyclosporin A immunosuppressive therapy. Transplant Proc 1994 ; 26: 3270–3271. MEDLINE
31. 31 Bennett WM. The nephrotoxicity of immunosuppressive drugs. Clin Nephrol 1995 ; 43 (suppl 1):S3–S7. MEDLINE